Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prebiotic and Probiotic Treatment Trial in Multiple Sclerosis

NCT04038541 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04038541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04038541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prebiotic and Probiotic Treatment Trial in Multiple Sclerosis
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Completed
Start date
March 11, 2020
Completion date
December 30, 2023
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

clinically isolated syndrome (cis), multiple sclerosis